Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disord... Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin. Show more
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces that further to its news...
NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5.35 | 11.1111111111 | 48.15 | 55 | 41.75 | 539757 | 47.94585823 | CS |
4 | 52.35 | 4552.17391304 | 1.15 | 79.02 | 0.94 | 9270305 | 35.64124683 | CS |
12 | 52.5 | 5250 | 1 | 79.02 | 0.94 | 3238441 | 34.62431861 | CS |
26 | 52.48 | 5145.09803922 | 1.02 | 79.02 | 0.9305 | 1515872 | 34.37246312 | CS |
52 | 52.12 | 3776.8115942 | 1.38 | 79.02 | 0.93 | 781226 | 33.7753267 | CS |
156 | 8.75 | 19.5530726257 | 44.75 | 79.02 | 0.93 | 1488300 | 14.48936294 | CS |
260 | 8.75 | 19.5530726257 | 44.75 | 79.02 | 0.93 | 1488300 | 14.48936294 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales